-
1
-
-
0037332228
-
Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma
-
Hessian PA, Highton J, Kean A, et al. Cytokine profile of the rheumatoid nodule suggests that it is a Th1 granuloma. Arthritis Rheum 2003;48:334-8.
-
(2003)
Arthritis Rheum
, vol.48
, pp. 334-338
-
-
Hessian, P.A.1
Highton, J.2
Kean, A.3
-
2
-
-
0033067487
-
Successful treatment of methotrexate induced nodulosis with D-penicillamine
-
Dash S, Seibold JR, Tiku ML, Successful treatment of methotrexate induced nodulosis with D-penicillamine. J Rheumatol 1999;26:1396-9.
-
(1999)
J Rheumatol
, vol.26
, pp. 1396-1399
-
-
Dash, S.1
Seibold, J.R.2
Tiku, M.L.3
-
3
-
-
33645728250
-
Corticosteroid injections reduce size of rheumatoid nodules
-
Baan H, Haagsma CJ, van de Laar MA, Corticosteroid injections reduce size of rheumatoid nodules. Clin Rheumatol 2006;25:21-3.
-
(2006)
Clin Rheumatol
, vol.25
, pp. 21-23
-
-
Baan, H.1
Haagsma, C.J.2
van de Laar, M.A.3
-
4
-
-
1342284388
-
Development and/or increase of rheumatoid nodules in rheumatoid nodules in rheumatoid arthritis patients following leflunomide therapy
-
Braun MG, Van Rhee R, Becker-Capeller D, Development and/or increase of rheumatoid nodules in rheumatoid nodules in rheumatoid arthritis patients following leflunomide therapy. Rheumatology 2004;63:84-7.
-
(2004)
Rheumatology
, vol.63
, pp. 84-87
-
-
Braun, M.G.1
Van Rhee, R.2
Becker-Capeller, D.3
-
5
-
-
0026628884
-
Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis; an analysis of ten cases
-
Kerstens P, Boerbooms AM, Jeurissen ME, et al. Accelerated nodulosis during low dose methotrexate therapy for rheumatoid arthritis; an analysis of ten cases. J Rheumatol 1992;19:867-1.
-
(1992)
J Rheumatol
, vol.19
, pp. 867-871
-
-
Kerstens, P.1
Boerbooms, A.M.2
Jeurissen, M.E.3
-
6
-
-
0036185035
-
Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept
-
Kekow J, Welte T, Kellner U, et al. Development of rheumatoid nodules during anti-tumor necrosis factor alpha therapy with etanercept. Arthritis Rheum 2002;46: 843-4.
-
(2002)
Arthritis Rheum
, vol.46
, pp. 843-844
-
-
Kekow, J.1
Welte, T.2
Kellner, U.3
-
7
-
-
70450195865
-
Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series
-
Toussirot E, Berthelot JM, Pertuiset E, et al. Pulmonary nodulosis and aseptic granulomatous lung disease occurring in patients with rheumatoid arthritis receiving tumor necrosis factor-alpha-blocking agent: a case series. J Rheumatol 2009;36:2421-7.
-
(2009)
J Rheumatol
, vol.36
, pp. 2421-2427
-
-
Toussirot, E.1
Berthelot, J.M.2
Pertuiset, E.3
-
8
-
-
64849115299
-
Marked regression of pulmonary rheumatoid nodules under etanercept therapy
-
Derot G, Marini-Portugal A, Maitre B, et al. Marked regression of pulmonary rheumatoid nodules under etanercept therapy. J Rheumatol 2009;36:437-9.
-
(2009)
J Rheumatol
, vol.36
, pp. 437-439
-
-
Derot, G.1
Marini-Portugal, A.2
Maitre, B.3
-
9
-
-
40749114497
-
Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial
-
Smolen JS, Beaulieu A, Rubbert-Roth A, et al. Effect of interleukin-6 receptor inhibition with tocilizumab in patients with rheumatoid arthritis (OPTION study): a double-blind, placebo-controlled, randomised trial. Lancet 2008;371:987-97.
-
(2008)
Lancet
, vol.371
, pp. 987-997
-
-
Smolen, J.S.1
Beaulieu, A.2
Rubbert-Roth, A.3
-
10
-
-
45349099110
-
Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules
-
Stamp LK, Easson A, Lehnigk U, et al. Different T cell subsets in the nodule and synovial membrane: absence of interleukin-17A in rheumatoid nodules. Arthritis Rheum 2008;58:1601-8.
-
(2008)
Arthritis Rheum
, vol.58
, pp. 1601-1608
-
-
Stamp, L.K.1
Easson, A.2
Lehnigk, U.3
|